Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(0.95) by 20 percent. This is a 33.91 percent increase over losses of $(1.15) per share from the same period last year. The company reported quarterly sales of $6.687 million which beat the analyst consensus estimate of $6.567 million by 1.82 percent. This is a 2.88 percent increase over sales of $6.500 million the same period last year.